NeoGenomics任命Warren Stone为首席执行官;第三季度收入为2.09亿美元

2026-10-06 04:13

NeoGenomics (NEO) announced on Monday that it appointed Warren Stone as CEO and a board member, effective January 4, 2027.
Current CEO Tony Zook will become executive chairman.
Lynn Tetrault will step down as board chair and will leave the board after the 2027 annual meeting, while Michael Kelly will become lead independent director.
Moreover, preliminary Q3 revenue is expected at approximately $209M, with next-generation sequencing revenue up about 28% year-over-year.
NeoGenomics expects to raise its full-year revenue guidance midpoint based on Q3 performance while reiterating its full-year adjusted EBITDA guidance.
The stock moved ~1.46% higher to ~$19.41 in the after-hours trading session.
Source: Press Release

More on NeoGenomics